With continued investment in mRNA research, Donald Trump could turn the stalemate against cancer into a decisive breakthrough ...

This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. Moderna and the BioNTech-Pfizer duo became heroes of the ...

New research found that mRNA vaccines for COVID-19 could enhance cancer treatments and help patients live longer.

Q3 earnings beat estimates but pipeline setback and lower 2025 guidance raise concerns. Full analysis of results and outlook.

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.

Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...

Akeso, Inc. (HKEX: 9926. HK) is pleased to announce that the first patient has been dosed in a Phase I clinical trial evaluating the personalized mRNA vaccine AK154. This trial is investigating AK154 ...

According to Nova One Advisor, the global mRNA synthesis & manufacturing market size is calculated at USD 1.58 billion in 2025 and is expected to be hit around USD 1.87 billion by 2034, growing at a ...

When Momar Ndao looks at the ingeniousness of the mRNA technology behind the COVID-19 vaccines, he sees hope in the fight against a category of diseases that blinded his mother and killed his uncle.

Research reveals mRNA COVID-19 vaccines may enhance cancer immunotherapy effectiveness, extending survival for lung and skin ...

Messenger ribonucleic acid (mRNA) is a code-carrying molecule that instructs your body to make proteins. Some proteins can treat or protect against a disease. For over a decade, Moderna has been ...

As the world waited with bated breath, scientists worked around the clock at breakneck speed to create an mRNA vaccine to protect against the novel coronavirus. Now, experts say that technology could ...